HAP’s Achievement Award Spotlight: Good Shepherd Penn Partners
July 12, 2019
Prevention initiatives are a significant aspect of the critical work that hospitals in Pennsylvania do to provide better care for their patients. Good Shepherd Penn Partners is making award-winning progress with their initiatives.
Good Shepherd Penn Partners in Philadelphia was awarded HAP’s 2019 In Safe Hands award with its initiative, Prevention of Central Line-Associated Bloodstream Infections in Long-Term Acute Care.
The goal was to achieve a 25 percent reduction in the CLABSI rate from April 2018 to January 2019.
A task force reviewed best practices, interviewed bedside staff, and did a retrospective chart review to develop a multifaceted initiative that was implemented during July 2018. Because most patients have their central lines inserted at other facilities, the focus was on preventing CLABSIs after insertion, with particular attention to daily chlorhexidine bathing and blood culturing practices.
The prevention initiative included:
- A recurring six-part educational series for bedside nurses
- Education for nurses and physicians about daily chlorhexidine bathing
- An electronic audit report to provide feedback about patients without active chlorhexidine orders
- The use of venipuncture alone for evaluation of potential bloodstream infections
The results were a significant decline in the rate of CLABSIs achieved after eight months. The 0.55 infection rate per 1,000 central line days during fiscal year (FY) 2019 represents an 80 percent reduction from FY 2018. Chlorhexidine bathing is ordered for, and delivered to, more than 95 percent of patients who have central lines.
Congratulations to Good Shepherd Penn Partners for reducing the rate of CLABSIs and for its receipt of a 2019 HAP Achievement Award. Learn more about this effort as well as other 2019 award-winning programs at HAP’s website.
Questions about the HAP Achievement Awards may be directed to HAP Member Services at (717) 561-5359.